<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37102641</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>LncRNA TUG1 relieves renal mesangial cell injury by modulating the miR-153-3p/Bcl-2 axis in lupus nephritis.</ArticleTitle><Pagination><StartPage>e811</StartPage><MedlinePgn>e811</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e811</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.811</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lupus nephritis (LN) is one of the most common and serious complications of systemic lupus erythematosus. Our experiments aimed to evaluate the molecular mechanisms of long noncoding RNA (lncRNA) TUG1 in a human renal mesangial cell (HRMC) model of LN.</AbstractText><AbstractText Label="METHODS">Cells were treated with lipopolysaccharide (LPS) to induce inflammatory damage. StarBase, TargetScan, and a luciferase reporter assay were used to predict and confirm the interactions between lncRNA TUG1, miR-153-3p, and Bcl-2. We determined the lncRNA TUG1 and miR-153-3p levels in LPS-induced HRMCs using quantitative reverse transcription PCR (RT-qPCR). MTT and flow cytometry analyses were used to detect HRMC proliferation and apoptosis, respectively. In addition, the expression of the apoptosis-related proteins Bax and Bcl-2 was evaluated using western blot analysis and RT-qPCR. Lastly, the secretion of inflammatory cytokines (IL-1&#x3b2;, IL-6, and TNF-&#x3b1;) was assessed using ELISA.</AbstractText><AbstractText Label="RESULTS">miR-153-3p directly targeted lncRNA TUG1. The level of lncRNA TUG1 was remarkably lower and miR-153-3p expression was markedly higher in LPS-treated HRMCs than in untreated cells. Transfection with TUG1-plasmid relieved LPS-induced HRMC injury, as evidenced by increased cell viability, inhibited apoptotic cells, reduced Bax expression, increased Bcl-2 level, and reduced secretion of inflammatory cytokines. Importantly, these findings were reversed by miR-153-3p mimic. We also found that miR-153-3p directly targeted Bcl-2 and negatively regulated Bcl-2 expression in HRMCs. In addition, our findings suggest that miR-153-3p inhibitor relieved LPS-induced HRMC injury via the upregulation of Bcl-2.</AbstractText><AbstractText Label="CONCLUSION">lncRNA TUG1 alleviated LPS-induced HRMC injury through regulation of the miR-153-3p/Bcl-2 axis in LN.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lingxi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Wuhan City Puren Hospital, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Liping</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0070-318X</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Hubei Integrated Traditional Chinese and Western Medicine Hospital, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051028">bcl-2-Associated X Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C556500">MIRN153 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598536">TUG1 long noncoding RNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051028" MajorTopicYN="N">bcl-2-Associated X Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050527" MajorTopicYN="N">Mesangial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">lncRNA TUG1</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">miR-153-3p/Bcl-2 axis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37102641</ArticleId><ArticleId IdType="pmc">PMC10091205</ArticleId><ArticleId IdType="doi">10.1002/iid3.811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saettini F, Cattoni A, Redaelli M, et al. Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia. Acta Paediatr (Stockholm). 2021;110(2):643&#x2010;651. 10.1111/apa.15593</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15593</ArticleId><ArticleId IdType="pubmed">33025591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Chen HK, Wu BJ, et al. Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia. Schizophr Res. 2021;237:166&#x2010;173. 10.1016/j.schres.2021.08.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2021.08.032</ArticleId><ArticleId IdType="pubmed">34536750</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanha N, Hansen R, Yang J, et al. Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 2020;49(2):122&#x2010;130. 10.1080/03009742.2019.1650107</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009742.2019.1650107</ArticleId><ArticleId IdType="pubmed">31612777</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka M, Koga T, Sumiyoshi R, et al. Novel multiple heterozygous NUDT15 variants cause an azathioprine&#x2010;induced severe leukopenia in a patient with systemic lupus erythematosus. Clin Immunol. 2019;200:64&#x2010;65. 10.1016/j.clim.2019.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.02.004</ArticleId><ArticleId IdType="pubmed">30742971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis&#x2010;role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci. 2019;20(24):6231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhang X, Si F. MicroRNA&#x2010;124 represents a novel diagnostic marker in human lupus nephritis and plays an inhibitory effect on the growth and inflammation of renal mesangial cells by targeting TRAF6. Int J Clin Exp Pathol. 2019;12(5):1578&#x2010;1588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6947142</ArticleId><ArticleId IdType="pubmed">31933975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao HL, Liu ZJ, Huang PL, Yue YL, Xi JN. lncRNA&#x2010;RMRP promotes proliferation, migration and invasion of bladder cancer via miR&#x2010;206. Eur Rev Med Pharmacol Sci. 2019;23(3):1012&#x2010;1021. 10.26355/eurrev_201902_16988</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_201902_16988</ArticleId><ArticleId IdType="pubmed">30779067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Zheng X, Cheng J, Zhang K, Ma C. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR&#x2010;148b/IGF2 axis in ox&#x2010;LDL&#x2010;stimulated VSMC and HUVEC. Life Sci. 2020;243:117287. 10.1016/j.lfs.2020.117287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117287</ArticleId><ArticleId IdType="pubmed">31926240</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao HY, Li D, Wang YP, Lu HX, Sun J, Li HB. Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients. Int J Rheum Dis. 2020;23(3):428&#x2010;434. 10.1111/1756-185X.13786</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13786</ArticleId><ArticleId IdType="pubmed">31944629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Wu J, Liu L, et al. Serum miRNA&#x2010;371b&#x2010;5p and miRNA&#x2010;5100 act as biomarkers for systemic lupus erythematosus. Clin Immunol. 2018;196:103&#x2010;109. 10.1016/j.clim.2018.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.10.004</ArticleId><ArticleId IdType="pubmed">30304699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Ji Y, Wang X, et al. Relationship of miRNA&#x2010;146a to systemic lupus erythematosus: a PRISMA&#x2010;compliant meta&#x2010;analysis. Medicine. 2020;99(40):e22444. 10.1097/MD.0000000000022444</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000022444</ArticleId><ArticleId IdType="pmc">PMC7535641</ArticleId><ArticleId IdType="pubmed">33019429</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Li X, Duan M, et al. MiR&#x2010;153&#x2010;3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord&#x2010;derived mesenchymal stem cells in patients with systemic lupus erythematosus. Autoimmunity. 2020;53(4):201&#x2010;209. 10.1080/08916934.2020.1750011</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2020.1750011</ArticleId><ArticleId IdType="pubmed">32321315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Amelio J, Gairy K, et al. Systemic lupus erythematosus, lupus nephritis and end&#x2010;stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011&#x2010;1020. 10.1177/0961203320932219</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320932219</ArticleId><ArticleId IdType="pmc">PMC7425376</ArticleId><ArticleId IdType="pubmed">32571142</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamuro M, Takahashi T, Ota Y, et al. Intestinal diffuse large B&#x2010;cell lymphoma in a patient with systemic lupus erythematosus. Case Rep Gastrointest Med. 2020;2020:7947540. 10.1155/2020/7947540</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7947540</ArticleId><ArticleId IdType="pmc">PMC7171631</ArticleId><ArticleId IdType="pubmed">32328319</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira RC, Oliveira IS, Santiago MB, Sousa Atta MLB, Atta AM. High avidity dsDNA autoantibodies in Brazilian women with systemic lupus erythematosus: correlation with active disease and renal dysfunction. J Immunol Res. 2015;2015:1&#x2010;5. 10.1155/2015/814748</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/814748</ArticleId><ArticleId IdType="pmc">PMC4637097</ArticleId><ArticleId IdType="pubmed">26583157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LH, Xiao B, Zhong M, et al. LncRNA NEAT1 accelerates renal mesangial cell injury via modulating the miR&#x2010;146b/TRAF6/NF&#x2010;&#x3ba;B axis in lupus nephritis. Cell Tissue Res. 2020;382(3):627&#x2010;638. 10.1007/s00441-020-03248-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03248-z</ArticleId><ArticleId IdType="pubmed">32710276</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, Zhu Q, Fan J. lncRNA TUG1 promotes atherosclerosis progression by targeting miR&#x2010;382&#x2010;5p. Int J Clin Exp Pathol. 2021;14(9):972&#x2010;979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493262</ArticleId><ArticleId IdType="pubmed">34646415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan MX, Ji CY, Gao HQ, Sheng XY, Xie WX, Yin Q. lncRNA TUG1 regulates angiogenesis via the miR2045p/JAK2/STAT3 axis in hepatoblastoma. Mol Med Rep. 2021;24(2):553. 10.3892/mmr.2021.12192</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12192</ArticleId><ArticleId IdType="pubmed">34080023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Bai X, Yan Z, Guo X, Zhang Y. The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1&#x2010;miR&#x2010;145&#x2010;5p&#x2010;TRPC6 pathway. Biochem Cell Biol. 2021;99(2):249&#x2010;260. 10.1139/bcb-2020-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2020-0017</ArticleId><ArticleId IdType="pubmed">32985219</ArticleId></ArticleIdList></Reference><Reference><Citation>Li FP, Lin DQ, Gao LY. LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA&#x2010;21/PTEN axis. Eur Rev Med Pharmacol Sci. 2018;22(21):7439&#x2010;7447. 10.26355/eurrev_201811_16284</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_201811_16284</ArticleId><ArticleId IdType="pubmed">30468492</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Liu Y, Lv XW, Dai RX, Yang XH, Kong BH. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR&#x2010;132&#x2010;3p/HDAC3 axis. Am J Physiol&#x2010;Heart Circ Physiol. 2020;318(2):H332&#x2010;H344. 10.1152/ajpheart.00444.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00444.2019</ArticleId><ArticleId IdType="pubmed">31858814</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Liao W, Yi Z, Xiang W, He X. Association of miRNA&#x2010;145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis. Int J Clin Exp Pathol. 2015;8(10):12646&#x2010;12656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680399</ArticleId><ArticleId IdType="pubmed">26722454</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter R, Meade A, Potter S, Cooper RL. Rapid and direct action of lipopolysaccharide (LPS) on skeletal muscle of larval drosophila. Biology. 2021;10(12):1235. 10.3390/biology10121235</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10121235</ArticleId><ArticleId IdType="pmc">PMC8698716</ArticleId><ArticleId IdType="pubmed">34943150</ArticleId></ArticleIdList></Reference><Reference><Citation>Shui HA, Ka SM, Wu WM, et al. LPS&#x2010;evoked IL&#x2010;18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology. 2007;46(8):1277&#x2010;1284. 10.1093/rheumatology/kem136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem136</ArticleId><ArticleId IdType="pubmed">17569745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, An W, Moming A, Tuerdi M. Long non&#x2010;coding RNA TUG1 knockdown repressed the viability, migration and differentiation of osteoblasts by sponging miR&#x2010;214. Exp Ther Med. 2022;23(3):203. 10.3892/etm.2022.11126</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11126</ArticleId><ArticleId IdType="pmc">PMC8794542</ArticleId><ArticleId IdType="pubmed">35126706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang L, Xu G. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA&#x2010;221&#x2010;3p/KIT axis. Clin Hemorheol Microcirc. 2020;76(3):425&#x2010;437. 10.3233/CH-200906</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-200906</ArticleId><ArticleId IdType="pubmed">32804119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanno Y, Miyashita M, Seishima M, Matsuo O. &#x3b1;2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses. Immun Inflamm Dis. 2020;8(3):267&#x2010;278. 10.1002/iid3.302</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.302</ArticleId><ArticleId IdType="pmc">PMC7416015</ArticleId><ArticleId IdType="pubmed">32237065</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Pang G, Huang YG, Li C. miR&#x2010;133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis. Exp Mol Pathol. 2020;114:104384. 10.1016/j.yexmp.2020.104384</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2020.104384</ArticleId><ArticleId IdType="pubmed">31987844</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>